MacLaughlinJAAndersonRRHolickMFSpectral character of sunlight modulates photosynthesis of previtamin D and its photoisomers in human skin. Science1982; 216: 1001–3
2.
HolickMFMacLaughlinJAClarkMBHolickSAPottsJTAndersonRRPhotosynthesis of previtamin D in human skin and the physiologic consequences. Science1980; 210: 203–5
3.
HolickMFMacLaughlinJADoppeltSARegulation of cutaneous previtamin D3 photosynthesis in man: Skin pigment is not an essential regulator. Science1981; 211: 590–3
4.
WebbARde CostaBHolickMFEffect of winter solar irradiation on the photochemistry of 7-dehydrocholesterol, its photoisomers, and vitamin D. Photochem Photobiol1986; 116s: 43s
BattacharjaMMDe LucAFThe regulation of rat liver calciferol-25-hydroxylase. J Biol Chem1973; 248: 2963–73
7.
TuckerGIIIGaynorREHoussleMRVitD3 25-hydroxylase: Tissue occurrence and apparent lack of regulation. Arch Biochem Biophys1973; 155: 47–57
8.
StampTCBRandJMSeasonal changes in human plasma levels of 25 hydroxycholecalciferol. Nature1974; 247: 563–4
9.
FraserDRThe physiological economy of vitamin D. Lancet1983; i: 969–71
10.
FraserDRKodicekEUnique biosynthesis by kidney of a biologically active vitamin D metabolite. Nature1970; 228: 764–6
11.
PortaleAAHalloranBPMurphyMMMorrisRCJrOral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans. J Clin Invest1986; 77: 7–12
12.
FraserDRRegulation of metabolism of metabolism of vitamin D. Physiol Rev1980; 60: 551–613
13.
HolickMFAdamsJSVitamin D metabolism and biological function. In: AvioliLVKraneSMMetabolic Bone Diseases and Clinically Related Disorders. Philadelphia, London: WB Saunders, 1990: 155–95
14.
CorvolMUlmanAGarabedianMSpecific nuclear uptake of 24,25 dihydroxycholecalciferol a vitamin D3 metabolite active in cartilage. Febs Lett1980; 116: 273–6
15.
KraftOOffermannGSteldingerRGawlicDEffect of 1,25(OH)2D3 on 24,25(OH)2D3 on experimental rickets. Res Commun Chem Pathol Pharmacol1979; 26: 571–83
16.
GrayTKLoweWLesterGEVitamin D and pregnancy: The maternal foetal metabolism of vitamin D. Endocr Rev1981; 2: 264–74
17.
BickleDDNemanicMKWhitneyJOEliasPWNeonatal human foreskin keratinocytes produce 1,25 dihydroxyvitamin D3. Biochemistry1986; 25: 1545–8
18.
HowardGATurnerRTSherrardDJBaylinkDJHuman bone cells in culture metabolize 25 hydroxyvitamin D to 1,25 dihydroxy and 24, 25 dihydroxyvitamin D3. J Biol Chem1981; 256: 7738–40
19.
AdamsJDizMMGacadMARegulated expression of sarcoid macrophage 25 hydroxyvitamin D 1-hydroxyvitamin D 1-hydroxylation reaction. In: NormanAWSchaeferKGrigoleitHGGHerrathDV, eds. Vitamin D Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter1988; 855–6
20.
PikeJWOsteocalcin gene expression as a model for the genomic actions of the vitamin D hormone. In: NormalAWBouillonRThomassetM, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 55–63
21.
BarsonyJMcKayWMarxSJReceptor mediated rapid actions of steroid hormones: cGMP accumulation and reorganization of receptors. In: NormalAWBouillonRThomassetM, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 351–9
22.
BraidmanIPAndersonDCExtra-endocrine functions of vitamin D. Clin Endocrinol1985; 23: 445–60
23.
GensureRCRigglePCAntrobusSDFoxJWaltersMRAre there two classes of 1,25 dihydroxyvitamin D receptors? In: NormalAWBouillonRThomassetM, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 106–7
24.
Naveh-ManyTKilavRSilverJRegulation of 1,25 dihydroxyvitamin D, receptor gene expression in the parathyroid gland. In: NormalAWBouillonRThomassetM, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 75–81
25.
McDonnelDPMangelsdorffDJPikeJWHausslerMRO'MalleyBWMolecular cloning of complementary DNA encoding avian receptor for VitD. Science1987; 235: 1214–17
26.
BakerARMcDonnellDPHughesMCrispTMMangelsdorfDJHausslerMRCloning and expression of full length CDNA encoding human vitamin D receptor. Proc Nat Acad Sci USA1988; 85: 3294–8
27.
HausslerMRTerpeningCMKomBSWhitfieldGKHausslerCAVitamin D receptors: structure, regulation and function. In: NormanAWSchaeferKGrigoleitHGGHerrathDV, eds. Vitamin D Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter, 1988: 208–14
28.
RaichelHKoeflerMDNormanAWThe role of vitamin D endocrine system in health & disease. New Eng J Med1989; 320: 980–91
29.
MacLaughlinJACantenylLHolickMKIncrease in (Ca2+)i in cultured human keratinocytes by 1,25(0 VitD3 is calcium dependent and coincides with increase in phosphotidylinositol metabolism. In: NormanAWSchaeferKGrigoleitHGGHerrathDV, eds. Vitamin D Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter, 1988: 340–1
30.
DupretJMBrunPPerretCLomriNThomassetMCuisiner-GleizsPTranscriptional and post-transcriptional regulator of VitD dependent calcium binding protein gene expression in rat duodenum by 1,25 dihydroxycholecalciferol. J Biol Chem1987; 262: 16553–7
31.
ThomassetMTenenhouseAVitamin D dependence of calbindin 9K and calbindin 28K synthesis in various rat tissues. In: NormanAWSchaeferKGrigoleitHGGHerrathDV, eds. Vitamin D Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter, 1988: 516–17
32.
NemereIYoshimotoYNormanAWCalcium transport in perfused duodenum from normal chicks; enhancement within 14 minutes of exposure to 1,25 dihydroxyvitamin D3. Endocrinology1984; 115: 1476–83
33.
DelucaHFVitamin D: the vitamin and hormone. Fed Proc1974; 33: 2211–19
34.
KuriharaNIshuzukeSKiyokiMHaketaYIkedaKKumegawaMEffects of 1,25-dihydroxyvitamin D3 on osteoblastic MC3T3-E1 cells. Endocrinology1986; 118: 940–7
35.
PanLCPricePAThe effect of transcriptional inhibitors on the bone γ-carboxyglutamic acid protein response to 1,25-dihydroxyvitamin D3 in osteosarcoma cells. J Biol Chem1984; 259: 5844–7
36.
RowDWKheanBERegulation of collagen synthesis in fetal rat calvaria by 1,25 dihydroxyvitamin D3. J Biol Chem1982; 257: 8009–15
37.
ChambersTJThe role of 1,25-dihydroxyvitamin D3 in the generation and regulation of osteoclasts. In: NormanAWSchaeferKGrigoleitHGGHerrathDV, eds. Vitamin D Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter, 1988: 581–90
38.
HenryHLNormanAWVitamin D metabolism and biological actions. Annu Rev Biochem1984; 4: 493–520
39.
SlatopolskyEDussoABrownAJamesDVitamin D—The endocrine system and secondary hyperparathyroidism. In: NormanAWBouillonRThomassetM, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 557–861
40.
RussellJLettieriDSherwoodLMSuppression of 1,25 dihydroxy D of transcription of pre-proparathyroid hormone. Endocrinology1986; 119: 2864–6
41.
RigbyWFCThe immunobiology of vitamin D. Immunology Today1988; 9: 54–8
42.
TsoukasCDProvvediniDMManolagaSC1,25 dihydroxyvitamin D3: a novel immunoregulatory hormone. Science1984; 224: 1438–40
43.
ReichelHKoefflerHPToblerANormanAW1α,25 dihydroxy vitamin D3 inhibits γ-interferon synthesis by normal human peripheral blood lymphocytes. Proc Nat Acad Set USA1987; 84: 3385–9
44.
ToblerAMillerCANormanAWKoefflerHP1,25-dihydroxy vitamin D3 modulates the expression of a lymphokine (granulocyte-macrophage colony-stimulating factor) post-transcriptionally. J Clin Invest1988; 81: 1819–23
45.
IhoSTakahashiTKuraFSugiyamaHHoshinoTThe effect of 1,25-dihydroxyvitamin D3 on in vitro immunoglobulin production in human B cells. J Immunol1986; 236: 4427–31
46.
ColstonKWNew concepts in vitamin D physiology. In: SmithR, ed. Vitamin D: Proceedings of a Closed Workshop. London: Royal Society of Medicine Services Ltd, 1992: 37–19
47.
GarlandCFGarlandFCShawKECemstockGWHelsingJKGorhamEDSerum 25 vitamin D and colon cancer: eight year prospective study. Lancet1989; ii: 1176–8
48.
HonmaYHozumiMAbeE1,25 dihydroxyvitamin D3 and 1 hydroxyvitamin D3 prolonged survival time of mice inoculated with myeloid leukemia cells. Proc Nat Acad Sci USA1983; 80: 201–4
49.
MonkerRNormalAKoefflerHPVitamin D compounds: effect on clonal proliferation and differentiation of human myeloid cells. J Clin Invest1984; 73: 731–8
50.
Editorial. Vitamin D: new perspectives. Lancet1987; i: 1122–3
51.
ManolagasSCVitamin D and its relevance to cancer. Anti Cancer Research1987; 7: 625–38
52.
ReitsmaPHRothberyPGAstrinSMRegulation of myc gene expression in HL60 leukaemia cells by vitamin D metabolite. Nature1983; 306: 492–5
53.
HolickMFSmithEPincusSSkin as the site of vitamin D synthesis and target tissue for 1,25 dihydroxyvitamin D3. Arch Dermal1987; 123: 1676–83
54.
KragballeKEfficacy and tolerability of calcipotriol in psoriasis. In: NormanAWBouillonRThomassetM, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 418–23
55.
DunniganMGPatonJPGHaasigMcNicol GWGarnerMDSmithCMLate rickets and osteomalacia in Pakistani community in Glasgow. Scot Med J1962; 7: 159–67
56.
EastwoodJBNisbetJAColstonKWAngLFlanaganAMChambersTJMaxwellJDPlasma 250H Vit D and PTH in detection of osteomalacia in Asian outpatients. Clin Sci1990; 78: 383–9
57.
IqbalSJKaddamIPossible widespread vitamin D deficiency in Asians in Leicester. In: HalloranSP, ed. Proceedings of the National Meeting. London: Association of Clinical Biochemists1989: 70
58.
WillisMRDayRCPhilipsJBBateneELPhytic acid and clinical rickets in immigrants. Lancet1975; i: 771–3
59.
HendersonJBDunniganMSMcIntoshWBAbdul-MotaalAAGettinbyGGlekinBMThe importance of limited exposure to UV radiation and dietary factors in aetiology of rickets: A risk factor model. Q J Med1987; 241: 413–25
60.
ClementsMRThe problem of rickets in UK Asians. J Human Nutr Dietet1989; 2: 105–16
61.
DunniganMGFraserSAMcIntoshWBMoseleyHSumnerDJThe prevention of vitamin D deficiency in the elderly. Scot Med J1986; 31: 144–9
62.
LipsPVitamin D nutrition in the elderly: Problems and recommendations. In: NormanAWBouillonRThomassetM, eds. Vitamin D. Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 758–64
63.
MacLaughlinJHolickMFAging decreases the capacity of human skin to produce vitamin D. J Clin Invest1985; 76: 1536–8
64.
AndersonICampbellAERDunnARuncimanJBMOsteomalacia in elderly women. Scot Med J1966; 11: 429–35
65.
HolickMFVitamin D requirements for elderly. Clin Nutr1986; 5: 121–9
66.
TurnerGBrownRCSilverASeymourGWoodheadJSRenal insufficiency and secondary hyperparathyroidism in elderly patients. Ann Clin Biochem1991; 28: 321–6
WebbARKlineLHolickMFInfluence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin End Metab1988; 67: 373–8
69.
ClarkCGCrooksJDawsonAAMitchellPEGDisordered calcium metabolism after Polya gastrectomy. Lancet1963; i: 734–8
70.
McLennanWJHamiltonJCLow plasma 25(OH)VitD without osteomalacia. Lancet1978; i: 1210
71.
HillmanLSHollisBSalomonsSMartinLSlatopolskyEMcAlisterWHaddadJAbsorption, dosage and effect on mineral homeostasis of 25 dihydroxycholecalciferol in premature infants. Comparison with 400 and 800iu Vit D2 supplementations. J Paed1985; 106: 981–9
72.
ClementsMRDaviesMFraserDRLumbGAMawerEBAdamsPHMetabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin Sci1987; 73: 659–64
73.
DentCERichersARoweDJFStampTCBOsteomalacia with anticonvulsant therapy in epilepsy. BMJ1970; 4: 69–72
74.
CorrandinoRADephaylhydantrin: Direct inhibition of vitamin D3-mediated calcium absorptive mechanism in organic cultured duodenum. Biochem Pharmacol1976; 25: 863–4
Editorial. Renal osteodystrophy. New Eng J Med1989; 321: 317–18
77.
LucasPABrownCAJonesCRWoodheadJSColesGAReduced 1,25(OH)2VitD3 may be responsible for the development of hyperparathyroidism in early chronic renal failure. Proc Eur Dial Trans Assoc1985; 22: 1124–8
78.
LlachFMassrySGOn the mechanism of secondary hyper-parathyroidism in moderate renal insufficiency. J Clin Endocrinol Metab1985; 61: 601–8
79.
WoodheadJSSilverACAshtonJPBrownRCMeasurement of circulating parathyroid hormone. Harm Res1989; 32: 97–100
80.
WilsonLFetsenfeldADreznerKLlacaFAltered divalent cation metabolism in early renal failure: role of 1,25 dihydroxyvitamin D. Kidney Int1985; 27: 565–73
81.
BrownEMWilkinsonREEastmanRCPallottaJMarynickSPAbnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure. J Clin Endocrinol Metab1982; 54: 172–9
82.
KorkorABReduced binding of (3H) 1,25 dihydroxyvitamin D3 in parathyroid glands of patients with renal failure. N Eng J Med1987; 316: 1573–7
83.
AndressDLNorrisKCCoburnJWSlatopolskyEASherrandDJIntravenous calcitriol in treatment of refractory osteitis fibrosa of chronic renal failure. N Eng J Med1989; 32: 274–9
84.
RiggsBLMeltonLJIIIInvolutional osteoporosis. N Eng J Med1986; 314: 1676–86
85.
ThakkerRVO'RiordanJLHInherited forms of rickets and osteomalacia. Clin Endocrinol Metab1988; 2: 157–91
86.
GlorieuxFHDelvinEEPseudo-vitamin D deficiency Rickets. In: NormanAWBouillonRThomassetM, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 238–45
87.
LebermanUAInborn errors in vitamin D metabolism—their contribution to the understanding of vitamin D metabolism. In: NormanAWSchaeferKGrigoleitHGHerraltDV eds. Berlin: Walter de Gruyter, 1988: 935–47
88.
HughesMRMalloyPJKiebackDGPoint mutations in the human vitamin D receptor gene associated with hypocalcaemic rickets. Science1988; 242: 1702–5
89.
MalloyPJHughesMRPikeJWFeldmanDVitamin D receptor mutations and hereditary 1,25 dihydroxy vitamin D resistant rickets. In: NormanAWBouillonRThomassetM, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 116–24
90.
RyanEAReissEOncogenous osteomalacia. Am J Med1984; 77: 501–11
91.
PapolousSClemensTLFraherLJLevinIGSandlerLMO'RiordanJLH1,25 Dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet1979; i: 627–30
92.
ThomsonRBJohnsonJKAnother family with acute vitamin D intoxication: Another case of familial hypercalcaemia. Postgrad Med J1986; 62: 1025–8
93.
DaviesMAdamsPHThe continuing risk of vitamin D intoxication. Lancet1978; i: 621–3
94.
PatersonCRVitamin D poisoning: Survey of causes in 21 patients with hypercalcaemia. Lancet1980; i: 1164–5
95.
HowardJEMeyerRJIntoxication with vitamin D. J Clin Endocrinol1948; 8: 895–910
96.
MawerEBHannJTBerryJLDaviesMVitamin D metabolism in patients intoxicated with ergocalciferol. Clin Sci1985; 68: 135–41
97.
IqbalSJTaylorWHTreatment of vitamin D2 poisoning by induction of hepatic enzymes. BMJ1982; 285: 541–2
98.
LukaszkiewiczJProszynskaKLorencCRLudwiczaHHepatic microsomal enzyme induction treatment of vitamin D poisoning in a 7 month old baby. BMJ1987; 295: 1173
99.
KanisJARussellRGGRate of reversal of hypercalcaemia and hypercalcuria induced by vitamin D and its 1 alpha hydroxylated derivative. BMJ1977; i: 78–81
100.
DaviesMHayesMEMawerEBLambGAAbnormal VitD metabolism in Hodgkin's lymphoma. Lancet1985; ii: 1186–8
101.
PrinceMJShaeferPCGoldsmithRSChauserABHyperphosphatemia, tumoral calcinosis, associated with elevated serum 1,25-dihydroxycholecalciferol concentration. Am J Med1982; 96: 586–91
IqbalSJTaylorWHFraherLJO'RiordanJLHGlutethamide and circulating 1,25 dihydroxyvitamin D in vitamin D intoxication. BMJ1988; 297: 902–3
104.
HodkinsonHJMHodkinsonIRange for 25-hydroxy vitamin D in elderly subjects in whom osteomalacia has been excluded on histological and biochemical criteria. J Clin Exp Gerontol1980; 2: 133–9
105.
AbdulMotadl AGettinbyGMcIntoshWBSutherlandGRDunniganMGRelationship between radiological and biochemical evidence of rickets in Asian schoolchildren. Postgrad Med J1985; 61: 307–12
106.
PeachHCompstonJEVediSHortonLWLValue of plasma calcium, phosphate and alkaline phosphatase in diagnosis of histological osteomalacia. J Clin Path1982; 35: 625–30
107.
HodkinsonHM25-hydroxy vitamin D as a test for osteomalacia. Geriatr Med1982; 9: 6–7
108.
DavieMLawsonDEMJungRTLow 250H Vitamin D without osteomalacia. Lancet1978; i: 82
109.
KefetzKHodkinsonHMOsteomalacia in the presence of ‘normal’ serum 25-hydroxycholecalciferol concentration. BMJ1981; 283: 1437
110.
GuptaMMRoundJMStampTCBSpontaneous cure of vitamin D deficiency in Asians during summer in Britain. Lancet1974; i: 586–95
111.
MawerBEClinical implications of measurements of circulating vitamin D metabolite. Clin Endocrinol Metab1980; 9: 63–79
112.
PreeceMAFuraJAMcIntoshWBDunniganMGTomlinsonSO'RiordanJLHVitD deficiency among Asian immigrants to Britain. Lancet1973; i: 907–10
113.
McKennaMJFreeneyRMeadeAMuldowneyFPPrevention of hypovitaminosis D in the elderly. Calif Tissue Int1985; 37: 112–16
114.
DaviesMMawerEBHannJTStephensWPTaylorJLVitamin D prophylaxis in the elderly: A simple effective method suitable for large populations. Age Ageing1985; 14: 349–54
115.
DandonaPMohuideenJWeekaKoon JWFreedmanDBFonsecaVHeayTPersistence of parathyroid hormone hypersecretion after vitamin D treatment in Asian vegetarians. J Clin Endocrinol Metab1984; 59: 535–7
116.
StampTCBWalkerPGPerryWJenkinsMVNutritional osteomalacia and late rickets in Greater London, 1974–1979. Clinical and metabolic studies in 45 patients. J Clin Endocrinol Metab1980; 9: 81–105
117.
WaltersMRKollenkurchenUFoxJThe semantics of vitamin D deficiency. In: NormanAWBouillonRThomassetM, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 708–9
118.
CorlessDBeerMBoucherBJGuptaSPCohenRDVitamin-D status in long-stay geriatric patients. Lancet1975; i: 1404–6
119.
CorlessDGuptaSPSatarDASwitalaSBoucherBJVitamin D status of residents of an old people's home and long-stay patients. Gerontology1979; 25: 350–5
120.
WeismanYSehenRJEisenbergZSingle oral high-dose vitamin D3 prophylaxis in the elderly. J Am Geriatr Soc1986; 34: 5–18
121.
MacLennanWJHamiltonJCVitamin D supplements and 25-hydroxy-vitamin D concentrations in the elderly. BMJ1977; ii: 859–61
122.
BurnsJPatersonCRSingle dose vitamin D treatment for osteomalacia in the elderly. BMJ1985; 290: 281–2
123.
BikleDDGeeEMeasurement of free vitamin D metabolite levels: biological and clinical significant. In: NormanAWSchaeferKGrigoleitHGHerraltDV, es. Vit D Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter, 1988: 703–36
124.
BouillonRAuwerxJDekeyserLFeveryJLissensWDe MoorPSerum vitamin D metabolites and their binding proteins in patients with liver cirrhosis. J Clin Endocrinol Metab1984; 59: 86–9
125.
HaddadJGJrTransport of vitamin D and its metabolites. In: CoppDHTalmadgeRV, eds. Endocrinology of Calcium Metabolism. Amsterdam: Excerpta Medica, 1978: 186–90
126.
WoloszczukWDetermination of vitamin D binding protein by Scatchard analysis and estimation of a free 25-hydroxyvitamin D index. Clin Chim Acta1985; 145: 27–35
127.
BikleDDHalloranBPGeeERyzenEHaddadJGFree 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. J Clin Invest1986; 78: 748–52
JibaniMHodgesNHProlonged hypercalcaemia after industrial exposure to vitamin D3. BMJ1985; 290: 748–9
130.
DownPFPolakAReganRJA family with massive acute vitamin D intoxication. Postgrad Med J1979; 55: 89
131.
SlatopolskyEGrayRAdamsNDAdamsJLewisKLow serum levels of 1,25 dihydroxyvitamin D are not responsible for the development of secondary hyperparathyroidism in early renal failure. Kidney Int1978; 14: 73–8
132.
RitzEVitamin D therapy in renal failure— challenges and problems for the future. In: NormanAWSchaeferKGrigoleitHGGHerrathDV, eds. Vitamin D Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter, 1988: 1027–30
PeacockMHeyburnPJAaronJPlasma 1,25(OH)2 VitD concentration in nutritional osteomalacia. Lancet1979; ii: 195
135.
EismanJAWarkJDPrinceRLMoseleyJMModulation of plasma 1,25-dihydroxyvitamin D in man by stimulation and suppression tests. Lancet1979; ii: 931–2
136.
TsaiKSHeathHIIIKumarRRiggsBLImpaired vitamin D metabolism with aging in women. J Clin Invest1984; 73: 1668–72
137.
PorteousCEColdwellRDTraffordDJHMakinHLJRecent developments in the measurement of vitamin D and its metabolites in human body fluids. J Steroid Biochem1987; 6: 785–801
138.
SeamarkDATraffordDJHMakinHLJThe estimation of vitamin D and its metabolites in human plasma. J Steroid Biochem1981; 14: 111–23
139.
MayerESchmidt-GaykHInterlaboratory comparison of 25-hydroxyvitamin D determination. Clin Chem1984; 30: 1199–204
140.
CarterGDShuntF25 hydroxyvitamin D assays: Results of a national quality assessment. J Endocrinol1988; 117: Suppl. 112
141.
JongenMJMVan GinkelFCvan der VijghWJFKuiperSNetelenbosJCLipsPAn international comparison of vitamin D metabolite measurements. Clin Chem1984; 30: 399–403
142.
MonalagasSCReitzRHurstRHaddadJDeflosLGMulticentre comparison of 1,25 dihydroxycholecalciferol measurements in human serum. Lancet1983; i: 191–2
143.
MakinHLJColdwellRDTraffordDJHAssay for vitamin D and its metabolites: Do we need to improve accuracy and precision? In: NormanAWBouillonRThomassetM, eds. Vitamin D Gene Regulation Structure—Function Analysis and Clinical Application. Berlin: Walter de Gruyter, 1991: 635–43
144.
CarterGDAn international external quality assessment scheme for 25 hydroxyvitamin D assays. Comm Lab Med1992; 3: 130–5